Status:
COMPLETED
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.
Eligibility Criteria
Inclusion
- Adult patients with open-angle glaucoma or ocular hypertension;
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Visual acuity worse than 0.60;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00465803
Start Date
March 1 2007
Last Update
July 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle
Seattle, Washington, United States, 98104